Benitec Biopharma's total assets for Q4 2026 were AU$182.62M, a decrease of -2.34% from the previous quarter. DE:BJ9 total liabilities were AU$5.61M for the fiscal quarter, a 52.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.